Frontlight ResearchEarly access
Coronary artery disease trials in Argentina
1 of 4 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Banfield, Buenos Aires, Ciudad Autonoma, Ciudad de Buenos Aires, Ciudad Evita, Córdoba, Formosa, Hurlingham, Mar del Plata, Morón, Rosario, San Fernando, San Miguel de Tucumán, Santa Fe
- Age
- 18 years and over
- People
- 3,110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00